Creo Medical Group PLC

AIM:CREO Stock Report

Market Cap: UK£128.9m

Creo Medical Group Past Earnings Performance

Past criteria checks 0/6

Creo Medical GroupDie Erträge des Sektors -18.9% sind im Durchschnitt pro Jahr zurückgegangen, während die Erträge des Sektors Medical Equipment declining auf 9.5% pro Jahr stiegen. Die Einnahmen sind growing mit einer durchschnittlichen Rate von 43.9% pro Jahr gesunken.

Key information

-18.9%

Earnings growth rate

-4.5%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate43.9%
Return on equity-36.3%
Net Margin-85.5%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Market Cool On Creo Medical Group PLC's (LON:CREO) Revenues Pushing Shares 26% Lower

Mar 02
Market Cool On Creo Medical Group PLC's (LON:CREO) Revenues Pushing Shares 26% Lower

Revenues Tell The Story For Creo Medical Group PLC (LON:CREO) As Its Stock Soars 29%

Dec 29
Revenues Tell The Story For Creo Medical Group PLC (LON:CREO) As Its Stock Soars 29%

Is Creo Medical Group (LON:CREO) Weighed On By Its Debt Load?

Oct 06
Is Creo Medical Group (LON:CREO) Weighed On By Its Debt Load?

Creo Medical (LON:CREO) Is In A Good Position To Deliver On Growth Plans

Feb 03
Creo Medical (LON:CREO) Is In A Good Position To Deliver On Growth Plans

How Many Creo Medical Limited (LON:CREO) Shares Do Institutions Own?

Dec 09
How Many Creo Medical Limited (LON:CREO) Shares Do Institutions Own?

Revenue & Expenses Breakdown
Beta

How Creo Medical Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

AIM:CREO Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2329-25420
31 Mar 2328-26430
31 Dec 2227-27440
30 Sep 2226-28450
30 Jun 2226-28470
31 Mar 2226-26440
31 Dec 2125-25420
30 Sep 2124-23380
30 Jun 2122-21340
31 Mar 2116-21310
31 Dec 209-20280
30 Sep 205-19240
30 Jun 200-17200
31 Mar 200-17200
31 Dec 190-16190
30 Jun 190-13160
31 Mar 190-12140
31 Dec 180-10120
31 Dec 170-8100
30 Sep 170-890
30 Jun 170-880
30 Jun 161-560
29 Feb 161-340
28 Feb 150-230
28 Feb 141-230

Qualität der Erträge: CREO ist derzeit unrentabel.

Wachsende Gewinnspanne: CREO ist derzeit unrentabel.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Ergebnisentwicklung: CREO ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 18.9% pro Jahr zugenommen.

Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von CREO verglichen werden, da das Unternehmen derzeit nicht profitabel ist.

Erträge im Vergleich zur Industrie: CREO ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Medical Equipment (-12.2%) erschwert.


Return on Equity

Hohe Eigenkapitalrendite: CREO hat eine negative Eigenkapitalrendite (-36.28%), da es derzeit unrentabel ist.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.